MicroBioGen
  • Innovative yeast technology solutions
    Evolutionary technology. Revolutionary impact.

Geoff Bell – Co-founder, CEO and MD

  • Facilitated MicroBioGen’s transformation from pure research group into international commercial success
  • Prior experience includes over 15 years at two global investment banks in equity research and top rated research analyst

Jenny Hart – CFO

  • Jenny controls and manages all aspects of finance, HR and contracts at MicroBioGen
  • Responsible for external stakeholder management
  • Prior experience includes 23 years of commercial management at AGL Energy

Dr Philip Bell – Co-founder, Head of Research, Principal Scientist and Director

  • Leads the R&D team of 20 scientists on activities day-to-day, one of the principal scientists since MicroBioGen’s founding in 2001
  • Focused on driving innovation in the company through the highly trained research team

Dr Paul Attfield – Co-founder, Principal Scientist and Director

  • One of MicroBioGen’s original principal scientists, focused on commercialisation activities
  • With world-leading expertise in fermentation and biochemistry

Dr Ivan Rajkovic – Head of IP

  • Ex-Partner at Shelston IP
  • Significant IP expertise to ensure the break-throughs achieved are protected through an expanding patent portfolio

Andrew Fay – Corporate Development

  • Andy has been a key driver in the corporate development team for nearly a decade
  • High-level board experience across start-ups to large listed corporations has helped MicroBioGen negotiate several high-quality agreements

David Paton – Business Development

  • Over 18 years of corporate advisory experience at Citibank, Macquarie Capital, Morgan Stanley and Shaw and Partners
  • Extensive experience across M&A, ECM, DCM and business development / strategy execution